• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国健康相关结局测量通用版(CHROME-G):在中国普通人群中的心理测量测试以及与EQ-5D-5L和SF-6Dv2的比较表现

The generic version of China Health Related Outcomes Measures (CHROME-G): psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population.

作者信息

Xie Shitong, Wu Jing, Chen Pinan, He Xiaoning, Zhao Kun, Xie Feng

机构信息

School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.

Center for Social Science Survey and Data, Tianjin University, Tianjin, China.

出版信息

BMC Public Health. 2024 Dec 18;24(1):3485. doi: 10.1186/s12889-024-20999-4.

DOI:10.1186/s12889-024-20999-4
PMID:39695490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11656610/
Abstract

OBJECTIVES

The CHROME-G is the first generic preference-based measure developed in China. This study aimed to validate and compare the psychometric properties of the CHROME-G with the EQ-5D-5L and SF-6Dv2 among the Chinese general population.

METHODS

A representative sample of the Chinese general population in terms of age, gender, education, and urban/rural residence was recruited for an online survey. During the survey, respondents completed three instruments (first the CHROME-G, then the EQ-5D-5L and SF-6Dv2 in random order), demographic and health-related questions. The retest survey was carried out after two weeks. Ceiling/floor effects were first assessed. Convergent and divergent validity was examined using Spearman's rank correlation. Known-group validity was examined using the non-parametric Kruskal-Wallis H test and effect size. Test-retest reliability was assessed using the intraclass correlation coefficient and weighted Kappa statistics.

RESULTS

One thousand respondents (51.1% male, mean age 44.7 years) completed the first survey, with 378 also completing the retest survey. The mean ± SD completion time was 2.03 ± 0.58 min for the CHROME-G, and 1.37 ± 0.54 and 1.13 ± 0.38 min for the EQ-5D-5L and SF-6Dv2. Only the EQ-5D-5L had a ceiling effect of 35.1%. The range of Spearman rank's correlations was 0.45-0.62 for convergent validity and 0.14-0.46 for divergent validity. Among different health subgroups, the effect size for the CHROME-G, EQ-5D-5L and SF-6Dv2 was 1.348-3.416, 1.362-3.325 and 1.097-2.228, respectively. The ICC for test-retest was 0.791 for the CHROME-G, compared with 0.994 and 0.971 for the EQ-5D-5L and SF-6Dv2.

CONCLUSIONS

The CHROME-G showed good and comparable psychometric properties with the EQ-5D-5L and SF-6Dv2.

摘要

目的

CHROME-G是在中国开发的首个基于偏好的通用测量工具。本研究旨在验证CHROME-G在中国普通人群中的心理测量特性,并与EQ-5D-5L和SF-6Dv2进行比较。

方法

招募了一个在年龄、性别、教育程度和城乡居住方面具有代表性的中国普通人群样本进行在线调查。在调查过程中,受访者完成了三项测评工具(首先是CHROME-G,然后是EQ-5D-5L和SF-6Dv2,顺序随机)、人口统计学和健康相关问题。两周后进行了重测调查。首先评估天花板/地板效应。使用Spearman等级相关性检验收敛效度和区分效度。使用非参数Kruskal-Wallis H检验和效应量检验已知组效度。使用组内相关系数和加权Kappa统计量评估重测信度。

结果

1000名受访者(男性占51.1%,平均年龄44.7岁)完成了首次调查,其中378人也完成了重测调查。CHROME-G的平均完成时间为2.03±0.58分钟,EQ-5D-5L和SF-6Dv2的平均完成时间分别为1.37±0.54分钟和1.13±0.38分钟。只有EQ-5D-5L有35.1%的天花板效应。Spearman等级相关性范围在收敛效度方面为0.45至0.62,在区分效度方面为0.14至0.46。在不同健康亚组中,CHROME-G、EQ-5D-5L和SF-6Dv2的效应量分别为1.348至3.416、1.362至3.325和1.097至2.228。CHROME-G重测的组内相关系数为0.791,而EQ-5D-5L和SF-6Dv2分别为0.994和0.971。

结论

CHROME-G显示出与EQ-5D-5L和SF-6Dv2良好且相当 的心理测量特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd0/11656610/753d8ea54fce/12889_2024_20999_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd0/11656610/753d8ea54fce/12889_2024_20999_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddd0/11656610/753d8ea54fce/12889_2024_20999_Fig1_HTML.jpg

相似文献

1
The generic version of China Health Related Outcomes Measures (CHROME-G): psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population.中国健康相关结局测量通用版(CHROME-G):在中国普通人群中的心理测量测试以及与EQ-5D-5L和SF-6Dv2的比较表现
BMC Public Health. 2024 Dec 18;24(1):3485. doi: 10.1186/s12889-024-20999-4.
2
Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.SF-6Dv2 和 EQ-5D-5L 在中国人群健康调查中的测量性能比较。
Health Qual Life Outcomes. 2022 Jun 16;20(1):96. doi: 10.1186/s12955-022-02003-y.
3
Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China.在中国淋巴瘤患者中,EQ-5D-5L 和 SF-6Dv2 的心理计量学性能。
Eur J Health Econ. 2024 Dec;25(9):1471-1484. doi: 10.1007/s10198-024-01672-4. Epub 2024 Mar 7.
4
Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China.比较 EQ-5D-5L 和 SF-6Dv2 在超重和肥胖人群中的测量特性。
Health Qual Life Outcomes. 2023 Oct 31;21(1):118. doi: 10.1186/s12955-023-02202-1.
5
Validation of the Generic Version of China Health Related Outcomes Measures (CHROME-G) among individuals with type 2 diabetes in China.在中国 2 型糖尿病患者中验证通用版中国健康相关生存质量测定量表(CHROME-G)。
J Evid Based Med. 2024 Sep;17(3):615-625. doi: 10.1111/jebm.12642. Epub 2024 Sep 24.
6
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.中国一般人群中 EQ-5D-5L 与 SF-6Dv2 之间的比较性能和映射算法。
Eur J Health Econ. 2024 Feb;25(1):7-19. doi: 10.1007/s10198-023-01566-x. Epub 2023 Jan 29.
7
Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.迟发性庞贝病患者的 EQ-5D-3L、EQ-5D-5L 和 SF-6Dv2 的测量特性。
Eur J Health Econ. 2024 Dec;25(9):1505-1515. doi: 10.1007/s10198-024-01682-2. Epub 2024 Mar 12.
8
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China.在中国 COVID-19 患者中比较 EQ-5D-5L 和 SF-6Dv2 的测量特性。
Appl Health Econ Health Policy. 2024 Jul;22(4):555-568. doi: 10.1007/s40258-024-00881-5. Epub 2024 Apr 19.
9
Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students.EQ-5D-5L 和 SF-6Dv2 在测量中国高校教职工和学生人群健康状况的心理计量学性能。
BMC Public Health. 2023 Nov 22;23(1):2314. doi: 10.1186/s12889-023-17208-z.
10
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus.在中国2型糖尿病患者中,将糖尿病患者生活质量评估量表(ADDQoL)映射到欧洲五维健康量表(EQ-5D-5L)和简明健康效用指数6D第2版(SF-6Dv2)。
Health Qual Life Outcomes. 2025 Apr 30;23(1):46. doi: 10.1186/s12955-025-02371-1.

引用本文的文献

1
Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review.运用映射方法推导中国人群的健康效用值:一项系统评价
Appl Health Econ Health Policy. 2025 Aug 18. doi: 10.1007/s40258-025-00992-7.
2
Convergent validity, reliability and responsiveness of the AP-7D and EQ-5D-5L based on the survey for the general people in five countries: a new cultural-specific preference-based measure developed in east and southeast asia.基于五个国家普通人群调查的AP - 7D和EQ - 5D - 5L的收敛效度、信度和反应度:一种在东亚和东南亚开发的基于特定文化偏好的新测量方法
Health Qual Life Outcomes. 2025 Jun 13;23(1):61. doi: 10.1186/s12955-025-02393-9.
3

本文引用的文献

1
A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China.在中国患者、照护者和一般公众中,EQ-HWB 与 EQ-5D-5L 的头对头比较。
Value Health. 2024 Jul;27(7):848-856. doi: 10.1016/j.jval.2024.02.012. Epub 2024 Mar 5.
2
Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China.比较 EQ-5D-5L 和 SF-6Dv2 在超重和肥胖人群中的测量特性。
Health Qual Life Outcomes. 2023 Oct 31;21(1):118. doi: 10.1186/s12955-023-02202-1.
3
Measurement properties of the EQ-5D-5L in sub-health: evidence based on primary health care workers in China.
Translation, Cross-Cultural Adaptation and Reliability and Validity Studies of the Chinese Version of the Evidence-Based Practice and Evidence-Informed Practice Questionnaire.
《循证实践与循证 informed 实践问卷中文版的翻译、跨文化调适及信效度研究》
J Multidiscip Healthc. 2025 May 12;18:2661-2679. doi: 10.2147/JMDH.S518183. eCollection 2025.
亚健康人群 EQ-5D-5L 量表测量特性的研究:基于中国基层卫生保健工作者的证据。
Health Qual Life Outcomes. 2023 Mar 8;21(1):22. doi: 10.1186/s12955-023-02105-1.
4
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.中国一般人群中 EQ-5D-5L 与 SF-6Dv2 之间的比较性能和映射算法。
Eur J Health Econ. 2024 Feb;25(1):7-19. doi: 10.1007/s10198-023-01566-x. Epub 2023 Jan 29.
5
China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population.中国健康相关结局测量量表(CHROME):适用于中国人群的新型通用偏好测量量表的研制。
Pharmacoeconomics. 2022 Oct;40(10):957-969. doi: 10.1007/s40273-022-01151-9. Epub 2022 Jul 18.
6
Health-related quality of life among adults with haemophilia in China: A comparison with age-matched general population.中国成人血友病患者的健康相关生活质量:与年龄匹配的一般人群的比较。
Haemophilia. 2022 Sep;28(5):776-783. doi: 10.1111/hae.14615. Epub 2022 Jun 25.
7
Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.SF-6Dv2 和 EQ-5D-5L 在中国人群健康调查中的测量性能比较。
Health Qual Life Outcomes. 2022 Jun 16;20(1):96. doi: 10.1186/s12955-022-02003-y.
8
Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A.测量健康相关生活质量和幸福感:EQ-5D-5L、ReQoL-UI 和 ICECAP-A 的头对头心理测量比较。
Eur J Health Econ. 2022 Mar;23(2):165-176. doi: 10.1007/s10198-021-01359-0. Epub 2021 Aug 2.
9
The Unfolding Method to Explore Health-Related Quality of Life Constructs in a Chinese General Population.探索中国一般人群健康相关生命质量结构的展开方法。
Value Health. 2021 Jun;24(6):846-854. doi: 10.1016/j.jval.2020.12.014. Epub 2021 Mar 10.
10
Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.使用时间权衡和具有持续维度的离散选择实验对中国 SF-6Dv2 健康状态进行评估。
Pharmacoeconomics. 2021 May;39(5):521-535. doi: 10.1007/s40273-020-00997-1. Epub 2021 Feb 18.